Cancer feature: cnaPANCAN121

AC074389.6 AC091801.1 AC110781.3 ACTB ADAP1 AGMO AIMP2 AMZ1 ANKRD61 AP5Z1 ARL4A BRAT1 C1GALT1 C7orf26 C7orf50 CARD11 CCZ1 CCZ1B CHST12 COL28A1 COX19 CYP2W1 CYTH3 DAGLB DGKB EIF2AK1 EIF3B ELFN1 ETV1 FAM220A FBXL18 FOXK1 FSCN1 FTSJ2 GET4 GLCCI1 GNA12 GPER1 GPR146 GRID2IP HEATR2 ICA1 INTS1 IQCE KDELR2 LFNG MAD1L1 MAFK MEOX2 MICALL2 MIOS MMD2 NDUFA4 NUDT1 NXPH1 OCM PAPOLB PHF14 PMS2 PRKAR1B PSMG3 RAC1 RADIL RBAK RBAK-RBAKDN RNF216 RPA3 RPA3-AS1 RSPH10B RSPH10B2 SCIN SDK1 SLC29A4 SNX8 SUN1 THSD7A TMEM106B TMEM184A TNRC18 TTYH3 UNCX USP42 VWDE WIPI2 ZDHHC4 ZFAND2A ZNF12 ZNF853

Known Driver Genes: CARD11,PMS2,RAC1

Copy number alternation: gain

Palbociclib

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer